comparemela.com
Home
Live Updates
Trial Shows Precision Medicine in RA Remains Elusive : comparemela.com
Trial Shows Precision Medicine in RA 'Remains Elusive'
Histologic analysis did not sufficiently predict treatment response to certain medications, but methods involving gene expression and transcriptome analysis may be more promising.
Related Keywords
Minnesota ,
United States ,
Chicago ,
Illinois ,
University Medical Center ,
Netherlands ,
United Kingdom ,
Mayo Clinic In Rochester ,
Elena Myasoedova ,
Harrisr Perlman ,
Costantino Pitzalis ,
Queen Mary University Of London ,
Leiden University Medical Center ,
American College Of Rheumatology ,
Inflammatory Arthritis Subspecialty Group ,
European Union ,
Northwestern University Feinberg School Of Medicine ,
Centre For Experimental Medicine ,
Experimental Medicine ,
Queen Mary University ,
Helm Van Mil ,
Biological Therapies ,
Biologic Naive Patients With Rheumatoid Arthritis ,
American College ,
Northwestern University Feinberg School ,
Mayo Clinic ,
Rheumatoid Arthritis ,
A ,
Biologic Therapy ,
Tissue ,
Antineoplastic Drug ,
Nti Cancer Agents ,
Evacizumab ,
Rlotinib ,
Efitinib ,
Matinib ,
Ituximab ,
U11248 ,
Unitinib ,
Rastuzumab ,
Monoclonal Antibody ,
Etuximab ,
Genomics ,
Genomic Medicine ,
Edicine Genomic ,
Arthritis ,
Oint Inflammation ,
Biopsy ,
Precision Medicine ,
United Kingdom Site Content ,
Cardiovascular Imaging ,
Ardiac Imaging ,
V Imagi ,
comparemela.com © 2020. All Rights Reserved.